hemoglobin leve in iron deficiency anemia. Iron deficiency anaemia
Conditions
Interventions
Intervention 1: After Shiraz Portulaca Oleraceaseeds seeds were confirmed by the Pharmacognosy Department of Mashhad University of Medical Sciences, the experimental group received 0.3 g/kg of Portul
Treatment - Other
Treatment - Drugs
In the control group, during 4 weeks, 3 mg/kg of elemental iron was used with an average glass of water (200 ml) before the meal twice or three times a day, depending on the subject’s weight. The ferr
After Shiraz Portulaca Oleraceaseeds seeds were confirmed by the Pharmacognosy Department of Mashhad University of Medical Sciences, the experimental group received 0.3 g/kg of Portulaca Oleraceaseed
Sponsors
Vice-Chancellery for Research at Mashhad University of Medical Sciences and Kerman University of Med
Eligibility
Sex/Gender
Female
Age
15 Years to 18 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were as follows: Iranian nationality; being single; age range of 15-18 years; hemoglobin level of 10-12 g/dL; modified Mentzer index greater than 14; red cell distribution width more than 14.6%; serum ferritin level lower than12 ng/L. The exclusion criteria were as follows: following a special diet for obesity or Weight loss; hydrotherapy; vegetarianism; raw food diets; accidents resulting in burns, or bleeding, or blood transfusion in the past two months; use of chemical or herbal medications interfering with the treatment process; psychosomatic disorders affecting the treatment; parasitic infestations causing anemia; abnormal menstrual bleeding; chronic diarrhea; use of tobacco. The exclusion criteria during the study were as follows: the preliminary exclusion criteria ;intolerable side-effects of consuming Portulaca Oleracea or ferrous sulfate; stressful events during the study period; febrile diseases; diarrhea more than 48 hours; use of powder or tablets less than 5 days a week or non-use of powder or tablets for 4 days in a week; unwillingness to continue the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin level. Timepoint: Before and4 weeks after the intervention( the end of treatment). Method of measurement: Venous bloo samples. | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptoms of iron deficiency anemia. Timepoint: Before and 5 weeks after the intervention (one week after the end of treatment). Method of measurement: Visual Analog Scale (0-10) indicating the symptoms of iron deficiency anemia. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Asadi ZYDABADI
Islamic Azad University of Shahr-e-Babak
Outcome results
None listed